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a b s t r a c t 
Aspartame, an artiﬁcial sweetener, is very widely used in many foods and beverages. But there are contro- 
versies about its metabolite which is marked for its toxicity. Hence it is believed to be unsafe for human use.
Previous studies have reported on methanol exposure with involvements of free radicals on excitotoxicity 
of neuronal apoptosis. Hence, this present study is proposed to investigate whether or not chronic aspar- 
tame (FDA approved Daily Acceptable Intake (ADI),40 mg / kg bwt) administration could release methanol, 
and whether or not it can induce changes in brain oxidative stress status and gene and protein expression 
of anti-apoptotic Bcl-2 and pro-apoptotic Bax and caspase-3 in the rat brain region. To mimic the human 
methanol metabolism, Methotrexate (MTX)-treated Wistar strain male albino rats were used and after the 
oral administration of aspartame, the effects were studied along with controls and MTX-treated controls. 
Aspartame exposure resulted with a signiﬁcant increase in the enzymatic activity in protein carbonyl, lipid 
peroxidation levels, superoxide dismutase, glutathione-S-transferase, glutathione peroxidase and catalase 
activity in (aspartame MTX)-treated animals and with a signiﬁcant decrease in reduced glutathione, glu- 
tathione reductase and protein thiol, pointing out the generation of free radicals. The gene and protein 
expression of pro apoptotic marker Bax showed a marked increase whereas the anti-apoptotic marker Bcl-2 
decreased markedly indicating the aspartame is harmful at cellular level. It is clear that long term aspartame 
exposure could alter the brain antioxidant status, and can induce apoptotic changes in brain. 
c © 2014 The Authors. Published by Elsevier B.V. 
This is an open access article under the CC BY-NC-ND license 
( http: // creativecommons.org / licenses / by-nc-nd / 3.0 / ). ntroduction 
Aspartame ( l -aspartyl- l -phenylalanine methyl ester) is a low calo- 
ie artiﬁcial sweetener consumed by 200 million people worldwide. In 
965 aspartame was discovered by James Schlatter and was approved 
or use by the FDA in the 1970s. This sweetener is added to many soft 
everages, cakes etc., and its usage is increasing in health conscious 
ocieties as used in the weight reduction regime [ 1 ]. Upon ingestion 
pproximately 50% of the aspartame molecule is phenylalanine, 40% 
s aspartic acid and 10% is methanol [ 2 ]. Based on the literature study 
ruse [ 3 ] suggested that among the metabolites, methanol is a tox- 
cant that causes systemic toxicity. Parthasarathy et al. [ 4 ], reported 
hat methanol is primarily metabolized to formaldehyde and then to 
ormate, accompanied by the formation of superoxide anion and hy- 
rogen peroxide. There are a few reports on aspartame consumption 
n various neurological effects that include headache, insomnia and 
eizures [ 5 ], alterations in regional concentrations of catecholamine 
 6 ] which is accompanied with behavioral disturbances [ 7 ]. The accu- ulation of formate rather than methanol is itself considered to cause 
* Corresponding author . 
E-mail address: drsheeladeviibms@gmail.com (R. Sheeladevi). 
213-2317/ $ - see front matter c © 2014 The Authors. Published by Elsevier B.V. This is an
icenses / by-nc-nd / 3.0 / ). 
ttp://dx.doi.org/10.1016/j.redox.2014.04.011 methanol toxicity [ 8 ]. In addition to that, inhibition of cytochrome 
oxidase by formate also leads to the generation of superoxide, per- 
oxyl and hydroxyl radicals [ 9 ]. Methanol intoxication is associated 
with mitochondrial damage and increased microsomal proliferation, 
resulting in increased production of oxygen radicals [ 10 –11 ]. Oxida- 
tive stress is deﬁned as an imbalance between the elevated level of 
reactive oxygen species (ROS) and / or impaired function of the an- 
tioxidant defense system. Aspartame can affect the brain and their by 
the behavior [ 12 ]. Free radical overproduction directly causes death 
of immature cultured cortical neurons [ 13 ] and directly induces DNA 
damage [ 14 ]. 
Of all the organs in the body, the CNS takes more than its share of 
oxidative abuse. This is associated with the abundance of redox active 
transition metal ions, and the relative death of antioxidant defense 
system [ 15 ]. Chandra et al. [ 16 ], reported that reactive oxygen species 
(ROS) can trigger apoptosis. Besides the high oxygen consumption and 
the presence of high levels of polyunsaturated fatty acids (PUFA), the 
brain can be the target for free radicals [ 17 ] makes them even more 
venerable to oxidative stress. There is accumulating evidence of a di- 
rect involvement of the cellular redox status in the activation and the 
functioning of the apoptosis machinery [ 18 ]. Scaiano et al. [ 19 ], has 
reported that free radicals were responsible for induction of cellular  open access article under the CC BY-NC-ND license ( http: // creativecommons.org / 
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 damage that leads to chromosomal aberrations. Apoptosis, a form of
programmed cell death, plays an important role in embryogenesis and
in the normal development and maintenance of many adult tissues
[ 20 –21 ]. Apoptosis is tightly regulated by the expression or activa-
tion of several genes and proteins [ 22 ]. The initiation and execution of
apoptosis depend on activation of the receptor and / or mitochondrial-
dependent death pathways [ 23 –25 ]. The Bax (Bcl-2 associated X pro-
tein) gene was the ﬁrst identiﬁed pro-apoptotic member of the Bcl-2
protein family (B-cell lymphoma-2) [ 26 ]. In the nervous system, Bcl-2
protects against various stimuli that induce apoptotic neuronal death
[ 27 –28 ]. The mitochondrial Bcl2 gene family of proteins has been
demonstrated to be important for regulating apoptosis induced by
a variety of stimuli [ 26 , 29 ]. Caspases (cysteine-aspartic proteases or
cysteine-dependent aspartate-directed proteases) are a family of cys-
teine proteases that play an essential role in apoptosis (programmed
cell death). Caspase-3 activation may play a key role in triggering
apoptosis in neuronal cells which has also been suggested by Stefanis
et al. [ 30 ]. 
Due to the high liver folate content, rodents do not develop
metabolic acidosis during methanol poisoning as formate is metabo-
lized quickly. Only folate deﬁcient rodents are required to accumulate
formate in order to develop acidosis and to study methanol poisoning
[ 31 –32 ]. Hence, in this study, to mimic the human situation, a folate
deﬁciency status was induced by administering Methotrexate (MTX)
and folate deﬁcient diet. Many concerns have been raised about the
side effects of aspartame consumption and its safety. Our earlier study
report (for 75 mg / day aspartame) showed a marked increase in blood
methanol level, whether the chronic oral administration of aspartame
(40 mg / kg bwt) can also accumulate methanol after metabolism, and
further to investigate the antioxidant status in brain and there by any
alteration in the apoptotic genes forms the basis of this study. 
Materials and methods 
Animals 
Wistar strain male albino rats (200–220 g) were maintained under
standard laboratory conditions with water and food. For the folate
deﬁcient group folate deﬁcient diet was provided for 45 days prior
to the experiment and MTX was administered for a week before the
experiment. The animals were handled according to the principles of
laboratory care framed by the committee for the purpose of Control
and Supervision of Experiments on Animals (CPCSEA), Government
of India. Prior to the experimentation proper approval was obtained
from the Institutional Animal Ethical Committee (no: 01 / 032 / 2010 /
Aug-11). 
Chemicals 
Aspartame and Methotrexate were purchased from Sigma chemi-
cal company, St. Louis, MO, USA. Bovine serum albumin, Malondialde-
hyde from Sisco Research Laboratory, Bombay, India. Taq-polymerase,
DNTPs from (Genet Bio) China, RT enzyme kit from Thermo scientiﬁc,
USA and other molecular grade chemicals from Merck, Bangalore, In-
dia. Antibody was purchased from Pierce, USA. All other chemicals
were of analytical grade obtained from Sisco research Laboratory,
Bombay, India. 
Experimental design 
Aspartame dose 
The European Food Safety Authority conﬁrmed its Daily acceptable
intake (ADI) for aspartame 40 mg / kg bwt / day. In order to conﬁne
within the human permitted exposure limit this dose was selected.
Aspartame mixed in sterile saline was administered orally (40 mg / kgbody weight) and this dosage based on the FDA approved ADI limit
[ 33 ]. 
Groups 
The rats were randomly divided into three groups, namely, saline
control, folate deﬁcient (MTX-treated) control, and MTX-treated (fo-
late deﬁcient) with aspartame administered groups. Each group con-
sisted of six animals. Methotrexate (MTX) in sterile saline was admin-
istered (0.2 mg / kg / day) subcutaneously for 7 days to folate-deﬁcient
groups [ 34 ]. After 7 days administration with MTX, folate deﬁciency
was conﬁrmed by estimating the urinary excretion of formiminoglu-
tamic acid (FIGLU) [ 35 ]. From the eighth day, the MTX-treated (folate
deﬁcient) (third) group were administered orally with aspartame for
90 days, whereas the saline control and (folate deﬁcient) MTX treated
control groups received equivalent volumes of saline as an oral dose
and all animals were handled similarly. 
Sample collections 
The animals were sacriﬁced using higher dose of long acting pen-
tothal sodium (100 mg / kg bwt). The blood samples and isolation
of brain was performed between 8 and 10 a.m. to avoid circadian
rhythm induced changes. The brain was immediately removed and
washed with ice-cold phosphate buffered saline (PBS). Further dissec-
tion was made on ice-cold glass plate. The discrete regions of brain
(cerebral cortex, cerebellum, midbrain, pons medulla, hippocampus
and hypothalamus) were dissected according the method given by
Glowinski and Iverson [ 36 ]. The homogenate (10% w / v) of the indi-
vidual regions were prepared in a Teﬂon-glass tissue homogenizer,
using ice-cold PBS (100 mm, pH 7.4) buffer and centrifuged separately
in refrigerated centrifuge at 3000 rpm for 15 min. The supernatant
was used for analyzing the parameters in this study. 
Parameters 
Free radical scavenging enzymes 
Interference of free radicals in auto oxidation of pyrogallol
is used as a convenient assay for superoxide dismutase (SOD)
(EC.1.15.1.1) and expressed as units / min / mg protein [ 37 ]. For cata-
lase (EC.1.11.1.6) assay, standard hydrogen peroxide (0.2 M) was used
as substrate and the catalase activity was terminated at intervals of
0, 15, 30, and 60 s by addition of potassium dichromate–acetic acid
reagent and is expressed as units / min / mg protein [ 38 ]. Glutathione
peroxidase (EC.1.11.1.9) (GPx) activity was assayed by its ability to
utilize the standard glutathione in the presence of speciﬁc amount of
hydrogen peroxide (1 mM) and is expressed as units / min / mg protein
[ 39 ]. Glutathione-S-transferase (GST) was estimated by the method
of William et al. [ 40 ]. The activity of GST in tissues is expressed as
μmoles of 1-chloro-2,4-dinitrobenzene (CDNB) utilized / min / mg of
protein. 
Reduced glutathione (GSH) and glutathione reductase (GR) 
Reduced glutathione (GSH) was measured by its reaction with
5.5-dithiobis 2 nitro-benzoic acid (DTNB), to form a compound that
absorbs at 412 nm [ 41 ]. The level of GSH is expressed as μg of GSH /
mg of protein. The activity of glutathione reductase was estimated by
the method of Charles and Robert [ 42 ]. The activity of GR in tissues is
expressed as nanomoles of NADPH oxidized / min / mg protein. 
Lipid peroxidation 
Lipid peroxidation was measured by estimating malondialdehyde
(MDA), an intermediary product of lipid peroxidation, using thiobar-
bituric acid and is expressed as nanomoles of malondialdehyde (an
intermediary product of lipid peroxidation) / mg protein [ 43 ]. 
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 rotein estimation 
Discrete regions of brain tissues were homogenized in phosphate 
uffered saline (PBS) pH 7.4, and debris removed by centrifugation at 
2,000 g for 10 min. The supernatants were recovered and the protein 
oncentration was determined, according to the method of Lowry et 
l. [ 44 ], using bovine serum albumin as a standard. 
rotein carbonyls and thiol 
Protein carbonyl contents in homogenates prepared from cere- 
ral cortex, cerebellum, mid brain, pons medulla, hippocampus and 
ypothalamus were analyzed by 2,4-dinitrophenylhydrazine (DNPH) 
ethod as described by Levine et al. [ 45 ]. Protein bound (ie. in the 
embrane plus the soluble fraction) sulfhydryl concentration was 
etermined by the method of Sedlack and Lindsay [ 46 ] by subtracting 
he nonprotein sulfhydryl content from the total sulfhydryl content. 
issues were homogenized in 0.02 M EDTA solution and analyzed for 
rotein and sulfhydryl concentration. 
lasma methanol level using HPLC 
100 mL plasma was deproteinized with equal volume of acetoni- 
rile and centrifuged for 7 min at 4 ◦C [ 47 ]. The supernatant (20 mL) 
as analyzed for blood methanol and formate using an HPLC re- 
ractive index detector system (Diagram-5) (Shimadzu RID, Japan) 
equipped with Rezex ROA-organic acid column 300 × 7.5 mm 2 
.D., Phenomenex) with the security guard cartridge (AJO 4490 Phe- 
omenex). Column oven was used to maintain the temperature at 
0 ◦C. The mobile phase was 0.026 N sulfuric acid [ 48 ]. By using 
ethanol as an external standard, the recovery of methanol (HPLC 
rade) from blood was found to be 92–96%. Linearity for methanol was 
ound to be 5–500 mg / 100 mL. The detector sensitivity for methanol 
as found to be 5 mg / 100 mL and reproducibility was > 93%. 
solation of total RNA and reverse transcription-polymerized chain reac- 
ion (RT-PCR) 
Total RNA was isolated from cells using Trizol reagent following 
he method of Chomczynski and Sacchi [ 49 ]. The total RNA obtained 
as free from protein and DNA contamination. The reverse transcrip- 
ion step was performed by using the RT enzyme kit. Each 20 μL reac- 
ion mixture contained 5 μL Oligo(dT) (10 μM), 1 μL dNTP(10 μM), 
 μL First Strand buffer (5 × ), 1 μL DTT (0.1 M), 0.2 μL super Script III 
everse transcriptase ( 200 U / μL) varied quantity of RNA template (de- 
endent on RNA concentration) and RNase free water to make up the 
olume. Thermal cycling conditions for ﬁrst strand reaction consisted 
f 25 ◦C for 5 min, 50 ◦C for 45 min, 70 ◦C for 15 min and ﬁnally main-
ained at 4 ◦C for 5 min. PCR ampliﬁcation was performed using Taq 
NA Polymerase. Each 20 μL of sample contained 10 μL Master mix 
2 μM), 1 μL forward primer, 1 μL reverse primer for both gene of 
nterest and internal control consecutively, 2 μL RT sample, and 4 μL 
terile water. The mixture was kept at thermocycler and ampliﬁed 
or 35 cycles. Each thermocycling consisted of 94 ◦C for 30 s, varied 
nnealing temperature for each gene of interest for 30 s, 72 ◦C for 30 s 
-actin gene was co-ampliﬁed with apoptotic genes Bcl2, Bax and 
aspase 3 gene using the same procedures. The sense and antisense 
rimer for the study is tabulated in Table 1 . Ten cubic millimeters of 
ach PCR product was analyzed by gel electrophoresis on 2% agarose 
el. 
Agarose gel electrophoresis is an effective method for the identi- 
cation of puriﬁed DNA molecules [ 50 ]. Ampliﬁed product was ana- 
yzed by agarose gel electrophoresis with ethidium bromide staining. 
hen the gel containing cDNA was visualized with the help of ﬂu- 
rescent imager (Bio-Rad, USA). The Band intensity was quantiﬁed 
y Quantity One Software. The band intensiﬁcation for each enzyme 
RNA was normalized with that of the internal control β-actin using 
uantity One Software. Immunoblotting 
Tissue lysate was prepared with radio immunoassay buffer (RIPA) 
(Sigma) and protease inhibitor. Equal amounts of protein (60 μg) were 
electrophoresed on 10% SDS-PAGE. Following electrophoresis, sepa- 
rated proteins on SDS-PAGE gels were transferred on PVDF membrane 
(Millipore, USA). To block the nonspeciﬁc binding, the membranes 
were incubated blocking buffer with 5% skimmed milk for 2 h. Mem- 
branes were probed with primary antibodies active caspase 3, Bax, 
and Bcl2 protein (Biovision). Blots were incubated with horseradish 
peroxidase-conjugated secondary antibodies (1:10,000) (Merck). The 
bands were developed using ECL kit (Millipore, USA) in Chemi Doc 
image scanner from Bio-Rad. The band intensity was quantiﬁed by 
Quantity One software (Bio-Rad, USA). The membranes were stripped 
and reprobed for β-actin (Sigma) (1:5000) as an internal control. 
Histopathology 
Animals were deeply anesthetized with ketamine hydrochlo- 
ride. Rats were then perfused transcardially with phosphate-buffered 
saline, followed by buffered 10% formalin. The brain, was removed, 
and preserved in formalin until processed for histology. Then tissue 
was kept in the running water to remove formalin pigments, and de- 
hydrated with ascending grades of alcohol. After impregnation with 
parafﬁn wax, the parafﬁn blocks were made. They were processed 
and sections were cut with 10 μm in thickness using Spencer Lens, 
rotatory microtome (no. 820, NY, USA) and then stained with hema- 
toxylin and eosin as follows for brain. 
Immunohistochemical analysis 
Immunohistochemical analysis was carried out using the DAB uni- 
versal staining kit (Merck Genie, Bengaluru, India). The sections were 
deparafﬁnized in xylene and dehydrated in ethanol. After washing 
with PBS, slides were incubated with 3% H 2 O 2 in at room tempera- 
ture for 15 min to quench endogenous peroxidase activity. After anti- 
gen retrieval (15 min of autoclaving in 10 mM citrate buffer, pH 6.0), 
the slides were incubated with blocking solution (10% normal goat 
serum) for 5 min at room temperature. Then, the sections were in- 
cubated overnight with primary antibody. Subsequently, the sections 
were incubated with HRP secondary link antibody for 30 min at room 
temperature, washed with PBS. Then, the sections were treated with 
DAB chromogen for 15 min. Finally, the sections were washed with 
deionized water, counterstained with hematoxylin and mounted. 
Photographs were taken using Nikon microscope. 
Statistical analysis 
All the data from various groups were analyzed for the individual 
parameter by ANOVA. When there is a signiﬁcant ‘ F ’ test ratio the data 
were further analyzed with Tukey ’ s multiple comparison by ﬁxing the 
signiﬁcance at P < 0.05. For understanding the aspartame effect, the 
MTX treated groups act as strict controls. 
Result 
Enzymatic and non-enzymatic activities of free radical scavenging 
enzymes 
Superoxide dismutase (SOD) 
The data from various groups are presented as bar diagram with 
mean ± SD ( Fig. 1 ). Activity of SOD increased signiﬁcantly in aspar- 
tame treated MTX animals in the regions cerebral cortex ( F = 8.7, 
df = 2), cerebellum ( F = 8.9, df = 2), midbrain ( F = 25, df = 2),
pons-medulla ( F = 21, df = 2), hippocampus ( F = 119, df = 2) and 
hypothalamus ( F = 11, df = 2) when compared to control and MTX 
treated control. However, the control did not deviate from the MTX 
treated control animals. 
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Table 1 
The sense and antisense primer sequences of the gene of interest for PCR ampliﬁcation. 
Target gene Primer sequence (5 ′ → 3 ′ ) Amplicon size (bp) Anneal. temp / cycles 
Bax Sense: GACACCTGAGCTGACCTTGG 
Antisense: GAGGAAGTCCAGTGTCCAGC 
310 58 ◦C / 35 
Bcl2 Sense: GGGATGCCTTTGTGGAACTA 
Antisense: CTCACTTGTGGCCCAGGTAT 
138 56 ◦C / 35 
Caspase 3 Sense: AGTTGGACCCACCTTGTGAG 
Antisense: AGTCTGCAGCTCCTCCACAT 
298 55 ◦C / 35 
β-actin Sense: TCATGCCATCCTGCGTCTGGACCT 
Antisense:CGGACTCATCGTACTCCTGCTTG 
598 55 ◦C / 35 
Fig. 1. Effect of aspartame (40 mg / kg bwt) on superoxide dismutase (SOD) activity 
(units / mg of tissue protein) in rat brain discrete regions. CC = cerebral cortex; CB 
= cerebellum, MB = midbrain; PM = ponsmedulla; HP = hippocampus; HY = hy- 
pothalamus. Comparison and analysis were done by the one-way analysis of variance 
(ANOVA) ( n = 6), control group was compared with MTX control group and aspartame 
MTX group, MTX control group was compared with Aspartame MTX group. Control, 
MTX control –Methotrexate treated group; Asp + MTX – Aspartame + Methotrexate 
treated group.The data from various groups for the individual parameters are pre- 
sented as bar diagram with mean ± SD. signiﬁcance ﬁxed at P < 0.05, aspartame 
treated group when compared to control signiﬁcance is marked as * and MTX treated 
groups signiﬁcance is marked as #. 
Fig. 2. Effect of aspartame (40 mg / kg bwt) on catalase (CAT) activity (H 2 O 2 utilized 
/ min / mg protein) in rat brain discrete regions. 
 
 
 
 
 
 
 
 
 
Fig. 3. Effect of aspartame (40 mg / kg bwt) on glutathione peroxidase (GPx) concen- 
tration (units / mg of protein) in rat brain discrete regions. 
Fig. 4. Effect of aspartame (40mg / kg bwt)on reduced glutathione (GSH) concentration 
( μg of GSH / mg of protein) in rat brain discrete regions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Catalase 
The data from various groups are presented as bar diagram with
mean ± SD ( Fig. 2 ). The activity of catalase was increased markedly
in all the regions of brain (cerebral cortex ( F = 27, df = 2), cerebel-
lum( F = 34, df = 2), midbrain ( F = 53, df = 2), pons-medulla ( F = 14,
df = 2), hippocampus ( F = 25, df = 2) and hypothalamus ( F = 50,
df = 2)) in aspartame treated MTX animals with respect to control
and MTX treated control. However, the control did not deviate from
the MTX treated control animals. 
Glutathione peroxidase 
The data from various groups are presented as bar diagram with
mean ± SD ( Fig. 3 ). The activity of glutathione peroxidase wasmarkedly increased in the brain discrete regions (cerebral cortex
( F = 153, df = 2), cerebellum ( F = 151, df = 2), midbrain ( F = 43,
df = 2), pons-medulla ( F = 152, df = 2), hippocampus ( F = 150, df = 2)
and hypothalamus ( F = 237, df = 2)) of aspartame treated MTX ani-
mals when compared to control and MTX treated controls. However,
the control did not deviate from the MTX treated control animals. 
Reduced glutathione 
The data from various groups are presented as bar diagram with
mean ± SD ( Fig. 4 ). The activity of reduced glutathione was de-
creased in the entire brain regions studied such as cerebral cortex
( F = 62, df = 2), cerebellum ( F = 39, df = 2), midbrain ( F = 40, df = 2),
pons-medulla ( F = 38, df = 2), hippocampus ( F = 33, df = 2) and hy-
pothalamus ( F = 50, df = 2) in aspartame treated MTX animals when
compared to control and MTX treated control. The control and the
MTX treated controls did not differ from each other. 
Glutathione reductase 
The data from various groups are presented as bar diagram with
mean ± SD ( Fig. 5 ). The activity of glutathione reductase was de-
creased in all the brain discrete regions (cerebral cortex ( F = 4.11,
df = 2), cerebellum ( F = 6.67, df = 2), midbrain ( F = 8.42, df = 2),
pons-medulla ( F = 19, df = 2), hippocampus ( F = 172, df = 2) and
824 I. Ashok, R. Sheeladevi / Redox Biology 2 (2014) 820–831 
Fig. 5. Effect of aspartame (40 mg / kg bwt) on glutathione reductase (GR) concentra- 
tion (nM of NADPH oxidized / min / mg protein) in rat brain discrete regions. 
Fig. 6. Effect of aspartame (40 mg / kg bwt) on glutathione-S-transferase (GST) (CDNB 
conjugate formed / min / mg protein) in rat brain discrete regions. 
h
w
G
m
M
t  
c
(
(
s
L
m
m
m
r  
m
p  
a
l
P
m
t
a
i
(  
h
T
m
c
c  
Fig. 7. Effect of aspartame (40 mg / kg bwt) on lipid peroxidation (LPO) (nmoles of 
MDA / mg tissue) in rat brain discrete regions. 
Fig. 8. Effect of aspartame (40 mg / kg bwt) on protein carbonyl ( μg / mg protein) in rat 
brain discrete regions. 
Fig. 9. Effect of aspartame (40 mg / kg bwt) on protein thiol ( μg / mg protein) in rat 
brain discrete regions. 
 ypothalamus ( F = 20, df = 2)) of aspartame MTX treated animals 
hen compared to control and MTX treated controls. 
lutathione-S-transferase 
The data from various groups are presented as bar diagram with 
ean ± SD ( Fig. 6 ). Glutathione S transferase in the aspartame treated 
TX animals was markedly increased from the control and MTX 
reated control in the following regions cerebral cortex ( F = 71, df = 2),
erebellum ( F = 33, df = 2), midbrain ( F = 87, df = 2), pons-medulla 
 F = 19, df = 2), hippocampus ( F = 32, df = 2) and hypothalamus 
 F = 72, df = 2). The control as well as MTX treated animals show 
imilar results. 
ipid peroxidation 
The data from various groups are presented as bar diagram with 
ean ± SD ( Fig. 7 ). The level of lipid peroxidation was increased 
arkedly in all the regions of brain of aspartame treated MTX ani- 
als compared to control and MTX treated control in the following 
egions, cerebral cortex ( F = 73, df = 2), cerebellum ( F = 313, df = 2),
idbrain ( F = 206, df = 2), pons-medulla ( F = 362, df = 2), hippocam- 
us ( F = 135, df = 2) and hypothalamus( F = 811, df = 2). The control
s well as MTX treated controls showed similar lipid peroxidation 
evel. 
rotein carbonyl and thiol 
The data from various groups are presented as bar diagram with 
ean ± SD ( Figs. 8 and 9 ). The level of protein carbonyl was found 
o be increased in all the regions of brain in aspartame treated MTX 
nimals when compared with control as well as MTX treated control 
n the following regions cerebral cortex ( F = 143, df = 2), cerebellum 
 F = 23, df = 2), midbrain ( F = 24, df = 2), pons-medulla ( F = 14, df = 2),
ippocampus ( F = 64, df = 2) and hypothalamus ( F = 132, df = 2). 
he sulfhydryl (thiol) content of membrane proteins was decreased 
arkedly in the aspartame treated MTX animals when compared to 
ontrol and MTX treated control in the following regions, cerebral 
ortex ( F = 78, df = 2), cerebellum ( F = 129, df = 2), midbrain ( F = 53,df = 2), pons-medulla ( F = 275, df = 2), hippocampus ( F = 17, df = 2)
and hypothalamus ( F = 239, df = 2). The control as well as MTX treated 
animals show similar results. 
Plasma methanol level 
The data from various groups are presented as bar diagram with 
mean ± SD ( Fig. 10 ). The methanol level in the MTX treated control 
animals did not differ from the saline controls. However, the aspar- 
tame treated MTX animals showed a marked increase ( F = 140, df = 2) 
in the plasma methanol level from control and MTX treated control 
animals. The control as well as MTX treated animals showed no vari- 
ation. 
Expression of apoptotic factors 
Bax gene expression 
The results are given in Fig. 11 . Effect of long term aspartame on 
Bax, Bcl2 and caspase 3 mRNA expression in brain regions of Wistar 
albino rats. Using β-actin as an internal control the Bax gene ex- 
pression was studied. The Bax gene expression in the MTX control 
animals did not signiﬁcantly differ from the controls. However, the 
aspartame treated MTX animals showed a marked increase in the Bax 
I. Ashok, R. Sheeladevi / Redox Biology 2 (2014) 820–831 825 
Fig. 10. Effect of aspartame (40 mg / kg bwt) on blood methanol level (mM) in rat. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 gene expression in the brain discrete regions namely cerebral cor-
tex ( F = 57.62, df = 2), cerebellum ( F = 48.83, df = 2), hippocampus
( F = 97.80, df = 2) and hypothalamus ( F = 27.74, df = 2) from control
and MTX control animals. 
Bcl2 gene expression 
The results are given in Fig. 11 . Using β-actin as an internal con-
trol the Bcl2 expression is studied. The Bcl2 gene and expression in
the MTX control animals did not signiﬁcantly differ from the controls.
However, the aspartame treated MTX animals showed a marked de-
crease in the Bcl2 gene expression in the brain discrete regions namely
cerebral cortex ( F = 243.29, df = 2), cerebellum ( F = 58.96, df = 2),
hippocampus ( F = 114.14, df = 2) and hypothalamus ( F = 222.61,
df = 2) from control and MTX control animals. 
Activated caspase 3 
The results are given in Fig. 11 . The activated caspase 3 was stud-
ied by using β-actin as an internal control. The activated caspase 3 in
the MTX control animals did not signiﬁcantly differ from the controls.
However, the aspartame treated MTX animals showed a marked in-
crease in the activated caspase 3 in the brain discrete regions namely
cerebral cortex ( F = 174.98, df = 2), cerebellum ( F = 71.51, df = 2),
hippocampus ( F = 167.36, df = 2) and hypothalamus ( F = 5.08, df = 2)
from control and MTX control animals. 
Protein expression 
The results are given in Fig. 12 . Effect of long term aspartame in-
duced changes on Bcl2, Bax protein expression and activated caspase
3 in brain regions of Wistar albino rats. Using β-actin as an inter-
nal control the Bax protein expressions and activated caspase 3 were
studied. The Bax protein expressions and activated caspase 3 in the
MTX control animals did not signiﬁcantly differ from the controls.
However, the aspartame treated MTX animals showed a marked in-
crease in the Bax protein expression and activated caspase 3 in the
brain discrete regions namely cerebral cortex ( F = 23.59, df = 2), cere-
bellum ( F = 5.78, df = 2), and hippocampus ( F = 6.14, df = 2) from
control and MTX control animals. 
The Bcl2 protein expression in the MTX control animals did not
signiﬁcantly differ from the controls. However, the aspartame treated
MTX animals showed a marked decrease in the Bcl2 protein expres-
sion in the brain discrete regions namely cerebral cortex ( F = 34.07,
df = 2), cerebellum ( F = 81.03, df = 2), and hippocampus ( F = 60.35,
df = 2) from control and MTX control animals. 
Histopathology of brain 
Hematoxylin and Eosin (H&E) staining was performed on brain
hippocampal region. The results are given in ( Fig. 13 ) Effect of long
term aspartame (40 mg / kg bwt) on brain in Wistar albino rats, the
histomicrograph of brain stained by H&E. Upon gross examination,the normal neuronal morphology of pyramidal cell layers of Cornu
Ammonis 1, 2 and 3 and denate gyrus in the hippocampus of control
and MTX control were observed. Aspartame + MTX treated animal ’ s
shows the neuronal shrinkage of hippocampal layer due to degen-
eration of pyramidal cells, as visualized by H&E, when compared to
control and MTX controls. At higher magniﬁcation, H&E staining re-
vealed the abnormal neuronal morphology of pyramidal cell layers of
Cornu Ammonis 1, 2 and 3 and denate gyrus in the hippocampus of
aspartame treated MTX animals. In contrast, the aspartame treated
MTX animals showed the morphology of pyramidal cell layers ap-
peared disorganized, less intensely stained. Furthermore, the num-
ber of densely stained cell bodies in the pyramidal cell layers was
decreased in aspartame treated MTX animals and the morphology
was ﬁrst observed, suggesting the major afferent and efferent projec-
tions were undergoing widespread degeneration when compared to
the control animals and MTX treated control animals. 
Immunohistochemistry 
The results are given in Fig. 14 Effect of long term aspartame on
activated Caspase 3 and Bax protein expression in brain of Wistar
albino rats by immunohistochemistry. The photomicrograph shows
a signiﬁcant amount of neurons with immune reaction for activated
Caspase 3 and Bax protein as brown colored neuronal cells that are
considered as positive cells in the brain. Aspartame treated animals
brain region showed a marked increase in the activated caspase 3 and
Bax positive cells when compared to the control and MTX control. The
overall results indicate that aspartame could effectively bring changes
at cellular level. 
Discussion 
The present study conﬁrms that daily oral administration of
40 mg / kg of aspartame for 90 days led to alterations in the antioxidant
status by inducing free radicals in the brain. Ashok and Sheeladevi [ 51 ]
reported chronic exposure to aspartame (75 mg / kg bwt) induced de-
tectable methanol level in blood. In this study, the blood methanol
was elevated markedly after aspartame ingestion (40 mg / kg bwt)
which is the Daily acceptable intake permitted level. Ishak et al. [ 52 ],
reported that the derivatives of such metabolism are sometimes more
toxic than the initial substance which is true in the case of aspartame
as methanol is released after metabolism. According to Jeganathan
and Namasivayam [ 53 ] methanol is toxic to brain as the increased
blood methanol level can lead to severe shifts in brain monoamine
levels. It is well known that the nervous system is highly susceptible
for methanol intoxication. Due to the high liver folate content, ro-
dents do not develop metabolic acidosis during methanol poisoning
as formate is metabolized quickly. Only folate deﬁcient rodents are
required to accumulate formate in order to develop acidosis and to
study methanol poisoning [ 31 –32 ]. Hence, in this study, to mimic the
human situation, a folate deﬁciency status was induced to study the
methanol toxicity upon aspartame administration 
Free radical generation by methanol the toxic metabolite 
The free radical increase in the present study may be due to the
methanol that has been released during aspartame metabolism , as
the pathway leading to formate by catalase system is discontinued by
MTX administration. 
Maria et al. [ 54 ], provided the conclusive evidence about the gen-
eration of methanol-derived free radical metabolites. Goodman and
Tephly [ 55 ] reported that methanol is metabolized via three enzyme
systems, namely the alcohol dehydrogenase system, the catalase per
oxidative pathway and the microsomal oxidizing systems. Among
these microsomal oxidizing system is reported to be responsible for
free radical generation. In this study as folate deﬁcient animals are
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Fig. 11. Effect of long term aspartame on Bax, Bcl2 and active caspase 3 apoptotic expression in brain regions of Wistar albino rats. 
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tsed to mimic the human metabolism of methanol the catalase per 
xidative pathway is much declined. 
The cells are generally protected with an extensive antioxidant 
efense system. In this study the aspartame-treated MTX animals in- 
reased lipid peroxidation with alteration in the enzymatic and non- 
nzymatic scavenging system warrant the generation of free radicals. 
he increase in free radicals could not be ignored as cells can be 
njured or killed when the ROS generation overwhelms the cellular 
ntioxidant capacity [ 56 ]. The increase in the lipid peroxidation could 
ot be neglected as it is an auto catalytic mechanism leading to ox- 
dative destruction of cellular membranes [ 57 ]. Lipid peroxidation is 
nitiated by the abstraction of a hydrogen atom from the side chain 
f polyunsaturated fatty acids in the membrane [ 58 ]. The presence 
f lipid per oxides in a membrane disrupts its function by altering 
uidity and allowing ions such as Ca 2 + to leak across the membrane 
nd major contributor to the loss of cell function [ 59 ]. 
ree radical scavenging systems 
Antioxidants and free radical scavenging systems exist in the cells 
o protect it against the damaging effects of free radicals [ 60 ]. The present study showed that, the oral administration of aspartame 
could lead to a signiﬁcant elevation in SOD, CAT, and GPx compared 
to control group. In spite of the increase in SOD activity the elevation 
of lipid peroxidation specify the increased production of free radicals. 
Increased SOD activity could naturally accumulate the super oxides, 
H 2 O 2 and justify the increase in CAT and GPx for their increased 
activity after aspartame ingestion. Enhanced superoxide dismutase 
activity catalyzes the conversion of superoxide anions to H 2 O 2 which 
in turn could stimulate the second line of defense which includes glu- 
tathione peroxidase and catalase [ 61 ]. The increased SOD levels were 
only partially effective in combating the oxidative damage [ 62 ]. 
In free radicals production, the thiol glutathione (glycyl–glutamic 
acid–cysteine) is the most important cellular free radical scavenging 
system in the brain [ 63 ]. Gebicki and Gebicki [ 64 ] reported that free 
radicals induce the formation of the protein peroxides. Glutathione 
reductase plays an important role in cellular antioxidant protection 
by catalyzing the reduction of GSSG to GSH [ 65 ]. The reduced glu- 
tathione reductase activity observed may be one of the reason for 
the decrease in GSH level observed in the aspartame treated animals. 
There was a decrease in reduced GSH level observed in the MTX- 
aspartame treated group, since methanol metabolism depends upon 
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Fig. 12. Effect of long term aspartame on Bcl2, Bax, and active caspase 3 protein expression in brain regions of Wistar albino rats. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 reduced GSH. GSH is a cofactor needed for methanol detoxiﬁcation
[ 66 ]. Protein carbonyl content is actually the most general indicator
and far the most commonly used marker of protein oxidation [ 67 ].
In this study, there was an increase in the LPO, protein carbonyl lev-
els and a marked reduction in the protein thiol groups. According to
Patsoukis et al. [ 68 ], and Nikolaos et al. [ 69 ], the decreased protein
thiol in brain is due to the oxidative damage and well supporting the
present ﬁndings. Abhilash et al. [ 70 ], also reported a similar signiﬁ-
cant decrease in GSH concentration and glutathione activity in rats
brain following aspartame consumption (the dosage used by him was
500 and 100 mg / kg). It is essential to point out that even with the FDA
approved dosage of (40 mg / kg) similar alteration in the scavenging
system was observed.  Free radical and markers of apoptosis 
There is accumulating evidence of a direct involvement of the cel-
lular redox status in the activation and the functioning of the apop-
tosis machinery [ 18 ]. It is well known that neuronal death occurs
according to an apoptotic program [ 71 ]. There is an increase pro-
apoptotic Bax and caspases-3 expression with a marked decrease in
the Bcl-2 expression in aspartame with MTX treated group compared
to controls. Bcl-2 is a key regulator of apoptosis, promotes cell survival
either by inhibiting factors that activate caspases [ 72 ] or regulating
apoptosis by antagonizing the formation of heterodimers with other
Bcl-2 family members. Bcl-2 family proteins can indirectly regulate
the activity of caspases in related apoptotic pathways [ 73 ]. Bax, a
pro-apoptotic member, on the other hand, binds to the anti-apoptotic
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Fig. 13. Effect of long term aspartame (40 mg / kg bwt) on brain in Wistar albino rats, the histomicrograph of brain stained by hematoxylin and eosin. 
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acl-2 protein and thus acts by antagonizing the function of Bcl-2 to 
evoke apoptosis. The salient activation of apoptotic markers such as 
ax and caspases-3 and decreasing the regulator Bcl-2 by aspartame 
ould not be overlooked because induction of Bax is also reported to 
romote cytochrome c release from the mitochondria that eventually 
eads to apoptosis [ 74 ]. According to Mbazima et al. [ 75 ], a simulta- 
eous down-regulation of Bcl-2 protein and an up-regulation of Bax 
n neuronal cells and altering their ratio are in favor of apoptotic cell 
eath. 
Caspases are closely associated with apoptosis. The caspase- 
ascade system plays vital role in the induction, transduction and 
mpliﬁcation of intracellular apoptotic signals. Caspase-3, a key fac- 
or in apoptosis A depletion of intracellular GSH has been reported 
o occur with the onset of apoptosis [ 76 –77 ]. Hence the GSH deple- 
ion after aspartame administration observed in this study may be 
n additional factor for the apoptotic changes observed. In this study there was increased activated caspase 3 as well as its protein expres- 
sion with a decrease in reduced GSH and Bcl-2 in aspartame treated 
animals when compared to control and MTX treated control. 
The relation between free radicals and disease can be explained by 
the concept of ‘oxidative stress ’ elaborated by Sies [ 78 ]. Free radicals 
can also attack DNA strand to induce breaks and base modiﬁcations 
that can lead to point mutation [ 79 ]. Scaiano et al. [ 19 ] reported that 
free radicals were responsible for induction of cellular damage that 
leads to chromosomal aberrations. AlSuhzibani [ 80 ], reported that 
aspartame induces a signiﬁcant increase of chromosome aberration 
frequencies in mice compared to control providing a supporting scien- 
tiﬁc evidence that aspartame is toxic. The involvement of free radicals 
with tumor suppressor genes and proto-oncogenes suggests their role 
in the development of different human cancers [ 81 , 82 ]. The report of 
Soffritti et al. [ 83 ] highlighted that aspartame can induce cancer. Our 
previous study also well documented at 75 mg / kg bwt of aspartame 
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Fig. 14. Effect of long term aspartame on active caspase 3 and Bax protein expression in brain of Wistar albino rats by immunohistochemistry. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 treatment corroborated the free radical generation and behavioral
changes [ 84 , 85 ]. Hence, probably the free radicals accumulated due
to altered free radical scavenging enzymatic and non-enzymatic sys-
tem for the alteration observed in the cellular pro and anti-apoptotic
markers in discrete brain regions. The impact of aspartame induced
changes in brain is well represented in the histology of hippocam-
pal region. The aspartame treated animals showed a neuronal shrink-
age of hippocampal layer due to degeneration of pyramidal cells in this
study. The abnormal neuronal morphology of pyramidal cell layers of
Cornu Ammonis was also associated with the disorganized pyramidal
cell layers. The present study substantiates that down regulation of
Bcl2 and up regulation of Bax with activation of caspase 3 lead to the
apoptotic damage of neuronal cells in the brain regions, thus lending
support to our present ﬁndings. 
It may be concluded that aspartame exposure causes increased
production of free radicals and increased oxidative damage to pro-
teins in brain taken for the study. Increased free radicals and conse-
quent increase in the protein oxidative damages might be playing a
signiﬁcant role in the apoptotic neuronal death leading to the devel-
opment of neuronal toxicity in long-term aspartame exposure. 
Conclusion 
This study provides a scientiﬁc evidence to conclude that aspar-
tame is toxic to the body system and particularly in brain it increases
the free radicals and triggers the apoptosis. Aspartame consumption
in a long-term basis may affect the brain. It may be due to its metabo-
lite methanol aspartame may act as a chemical stressor as indicated by
the corticosteroid level. Still more studies are required to understand
more about aspartame. With the accumulating data from scientiﬁc
research must reach the public as aspartame is freely available in
pharmacy / super market and consumed largely by diabetic as well as
young people who want to reduce weight. Conﬂict of interest 
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